Table 4

Spearman correlation coefficients showing the correlations between measures of disease activity (BASDAI score) and MRI activity score and between inflammation (CRP level) and MRI activity score for patients in the combined golimumab group

	ASspiMRI-a score
	Baseline	Change from baseline to week 14	Change from baseline to week 104
CRP
Baseline	0.38^†	−0.44^‡	−0.40^‡
Change from baseline to week 14		0.45^‡	0.39^†
Change from baseline to week 104			0.38^†
ASDAS
Baseline	0.23	−0.30^*	−0.33^†
Change from baseline to week 14		0.35^†	0.19
Change from baseline to week 104			0.22
BASDAI
Baseline	0.06	−0.06	−0.16
Change from baseline to week 14		0.26^*	0.16
Change from baseline to week 104			0.11
BASFI
Baseline	0.08	0.01	−0.21
Change from baseline to week 14		0.19	0.10
Change from baseline to week 104			0.05
Total back pain
Baseline	0.06	−0.16	−0.16
Change from baseline to week 14		0.15	−0.01
Change from baseline to week 104			0.02
Morning stiffness
Baseline	−0.03	−0.07	−0.09
Change from baseline to week 14		−0.14	0.02
Change from baseline to week 104			0.06

↵* p<0.05.
↵† p<0.01.
↵‡ p<0.001.
ASDAS, ankylosing spondylitis disease activity score; ASspiMRI-a, ankylosing spondylitis spinal magnetic resonance imaging activity; BASDAI, Bath ankylosing spondylitis disease activity index; BASFI, Bath ankylosing spondylitis functional index; CRP, C-reactive protein.